Efficacy and Safety of Everolimus in Korean Patients with Metastatic Renal Cell Carcinoma Following Treatment Failure with a Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor

PURPOSE: The purpose of this study is to assess the efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma (mRCC) for whom initial treatment with a vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) has failed. MATERIALS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Kwonoh, Lee, Jae-Lyun, Ahn, Jin-Hee, Lee, Kyoo Hyung, Jeong, In-Gab, Song, Cheryn, Hong, Bumsik, Hong, Jun Hyuk, Ahn, Hanjong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206076/
https://www.ncbi.nlm.nih.gov/pubmed/25036572
http://dx.doi.org/10.4143/crt.2013.154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206076/
https://www.ncbi.nlm.nih.gov/pubmed/25036572
http://dx.doi.org/10.4143/crt.2013.154

Ejemplares similares